KEVIN M FARR
CIK 1194262 · CHIEF FINANCIAL OFFICER · last filed 2025-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.70M
Companies
4
Total Filings
153
Lifetime Open-Market Net
-$29.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PII | Director | 22,075 | $70.93 | $1.57M | -$1.54M | 57 | 2025-05-05 |
| Niagen Bioscience, Inc. (CDXC) Delisted | CHIEF FINANCIAL OFFICER | 41,625 | $7.87 | $327.6K | $158.5K | 14 | 2022-08-12 |
| MAT | Chief Financial Officer | 282,013 | $14.65 | $4.13M | -$28.01M | 41 | 2017-08-03 |
| BECKMAN COULTER INC (BEC) Delisted | Director | 5,790 | — | — | $97.6K | 40 | 2011-06-22 |
Recent Filings · Page 5 of 16
153 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-22 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | PII | Grant (A) | +376 | $29.4K | EDGAR |
| 2018-10-03 | PII | Grant (A) | +292 | $29.4K | EDGAR |
| 2018-09-11 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +5,000 | $17.5K | EDGAR |
| 2018-07-03 | PII | Grant (A) | +237 | $29.4K | EDGAR |
| 2018-05-22 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +5,000 | $19.1K | EDGAR |
| 2018-04-27 | PII | Grant (A) | +1,237 | $130.1K | EDGAR |
| 2018-04-04 | PII | Grant (A) | +260 | $29.4K | EDGAR |
| 2018-01-04 | PII | Grant (A) | +232 | $29.4K | EDGAR |
| 2017-10-10 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.